MindBio Therapeutics Advances Voice-Based AI Tech for Real-Time Impairment Detection

MindBio Therapeutics is developing a non-invasive AI voice analysis platform for real-time drug and alcohol impairment detection, targeting safety-critical industries like mining, with field testing planned for 2026.

SD Metrowire Staff
Technology
MindBio Therapeutics Advances Voice-Based AI Tech for Real-Time Impairment Detection

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) is advancing a voice-based artificial intelligence platform designed to detect drug and alcohol impairment in real time using short speech samples. The technology, which analyzes over 140 acoustic markers and is trained on more than 50 million data points, offers a non-invasive alternative to traditional breath, saliva, urine, and laboratory tests. According to the company, the platform aims to deliver rapid assessments through Edge AI kiosks, with initial field testing slated for 2026 and a commercial focus on South American mining operations.

The global alcohol and drug testing devices market is projected to grow from approximately $2.5 billion in 2025 to $4.2 billion by 2033, according to industry forecasts. MindBio sees opportunities to expand its platform beyond mining into aviation, construction, transportation, law enforcement, call centers, and healthcare. The company's proprietary research leverages AI prediction models to address increasing demand for faster, scalable workplace impairment detection.

MindBio's platform uses voice analysis to predict alcohol intoxication with notable accuracy. The enterprise system includes Edge AI kiosks that integrate bespoke hardware and software for detecting impairment in various environments. The technology's non-invasive nature and rapid results could significantly improve safety protocols in industries where impairment poses serious risks.

For more details, the full article is available at https://ibn.fm/Gw5Fa. Additional news and updates related to MBQIF can be found in the company's newsroom at https://ibn.fm/MBQIF.

MindBio Therapeutics is a biotechnology company commercializing AI prediction technologies for drug and alcohol intoxication detection via voice analysis. The AI model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy using only the human voice. The company is developing an enterprise platform including Edge AI kiosks for detection in mining, aviation, construction, and law enforcement.

Blockchain Registration

QR Code for Blockchain Registration